Jan 21, 2022, 01:00 AM by User Not Found

Bio-IT World | Life science researchers and drug discovery scientists today work in what, in my view, will be remembered in the future as the beginning of a “golden era” where the power of genetic information is connected to a wide range of other healthcare and lifestyle data to support better understanding of disease etiology, as well as the identification of candidates for drug targets and the discovery of new biomarkers that can be used to predict the presence or future development of a disease in an individual patient.

Jan 19, 2022, 01:00 AM by User Not Found

Bio-IT World | The nonprofit Consortium for Top-Down Proteomics recently proposed the Human Proteoform Project to generate a definitive reference set of the proteoforms produced from the genome. This will become a “seminal moment in science,” Neil Kelleher says, and the initiative is the next obvious step now that the Human Genome Project has provided the blueprint for how proteins get made.

Jan 18, 2022, 01:00 AM by User Not Found

Bio-IT World | Trends from the Trenches —Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as a technology is already successful, but he also believes it is still in its early days for healthcare and there are still significant challenges for use. Data organization, for example, must be solved so that AI models can be put to best use. Liu and his team recently explored how electronic health records could be better populated and curated to facilitate clinical trials.

Jan 14, 2022, 01:00 AM by User Not Found

Bio-IT World | Closing out the genomic presentations at the JP Morgan Healthcare Conference, Christian Henry, president and CEO of Pacific Biosciences, had the dual challenges of presenting PacBio’s year and future strategies as well as answering claims and announcements other companies made. He persevered.

Jan 13, 2022, 01:00 AM by User Not Found

Bio-IT World | At the JP Morgan Healthcare Conference—being held virtually again this year—pharma and biotech companies gave overviews of their 2021 business and their views of the future. Here are the highlights we noted from presentations from Regeneron, 10X Genomics, and Invitae

Jan 12, 2022, 11:34 AM by

Rousselot®, Darling Ingredients’ health brand and the world’s leader of collagen-based solutions, today announced that it has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine.

Jan 12, 2022, 11:34 AM by

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Jan 12, 2022, 11:34 AM by

PubHive Navigator SaaS platform now supports life science companies with workflow and information management needs across literature, aggregate reporting, and safety signal detection.

Jan 12, 2022, 11:34 AM by

Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will again help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.

Jan 12, 2022, 11:34 AM by

Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.

Jan 12, 2022, 11:34 AM by

PubHive Navigator expands safety and vigilance module, adding one-stop workflow and information management capabilities for aggregate reporting and authoring.

Jan 12, 2022, 11:34 AM by

Watson-Marlow Fluid-Technology Group (WMFTG) is pleased to confirm that it will be providing the sales and technical support for Flexicon in both Poland and the Czech Republic from January 2022.

Jan 12, 2022, 11:34 AM by

New Jersey-Based Health System Sees Increase in Online Appointment Bookings

Jan 12, 2022, 11:34 AM by

Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m.

Jan 11, 2022, 17:15 PM by User Not Found

Bio-IT World | Seqster announced today a multi-year partnership with The National Pancreas Foundation, a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, to create the country’s largest, most inclusive pancreatic disease patient registry. The registry uses Seqster technology to connect to any EHR, genomic DNA test, and wearable/remote monitoring device, providing patients with a complete longitudinal health record in real-time.

Jan 11, 2022, 01:00 AM by User Not Found

Bio-IT World | At the JP Morgan Healthcare Conference—being held virtually again this year—Illumina CEO Francis deSouza outlined Illumina’s record for 2021, announced several new partnerships, and teased new chemistry and new long read technologies.

Jan 10, 2022, 01:00 AM by User Not Found

Bio-IT World | We spoke with several players in the Bio-IT World vendor community to gain insights and predictions for the coming year. They predicted newer ‘omics, green chemistry, SaaS medical devices, federated learning, XNAT, protein sequencing, and more.

Jan 6, 2022, 16:59 PM by

Antibiotic prescription rates rise every winter, but new data from the charity Antibiotic Research UK (ANTRUK) and Costello Medical shows how the annual rise in winter prescribing can be reduced. To sustain this reduction in prescribing, ANTRUK is launching its ‘What’s Bugging You This Winter?’ campaign, calling on everyone to understand the role that they can play in tackling antibiotic resistance.

Jan 6, 2022, 16:58 PM by

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities Dokumeds brings complementary specialties and multinational footprint in Europe and beyond Research Triangle Park, NC – December 8, 2021 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.

Jan 6, 2022, 16:58 PM by